Gentile M, Manenti L
J Clin Med. 2025; 14(3).
PMID: 39941374
PMC: 11818541.
DOI: 10.3390/jcm14030702.
Novak J
Nephrology (Carlton). 2024; 29 Suppl 2:18-22.
PMID: 39327757
PMC: 11441619.
DOI: 10.1111/nep.14350.
Roberts L, Williams C, Oni L, Barratt J, Selvaskandan H
Indian J Nephrol. 2024; 34(4):297-309.
PMID: 39156850
PMC: 11326799.
DOI: 10.25259/ijn_425_23.
Zhou J, Shi W, Wu D, Wang S, Wang X, Min J
Nutrients. 2024; 16(13).
PMID: 38999730
PMC: 11243746.
DOI: 10.3390/nu16131978.
Chiarenza D, Verrina E, La Porta E, Caridi G, Ghiggeri G, Mortari G
J Clin Med. 2024; 13(9).
PMID: 38730994
PMC: 11084942.
DOI: 10.3390/jcm13092465.
Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis.
Zhang D, Xia B, Zhang X, Liang P, Hu X
BMC Urol. 2024; 24(1):56.
PMID: 38468247
PMC: 10926645.
DOI: 10.1186/s12894-024-01438-3.
Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy.
Stefan G, Alamartine E, Mariat C, Maillard N
Kidney Int Rep. 2024; 9(2):356-369.
PMID: 38344730
PMC: 10851005.
DOI: 10.1016/j.ekir.2023.11.005.
Bibliometric analysis of mucosal immunity in IgA nephropathy from 1990 to 2022.
Chen X, Yan Z, Pan Q, Zhang C, Chen Y, Liang X
Immun Inflamm Dis. 2024; 12(1):e1156.
PMID: 38270317
PMC: 10807354.
DOI: 10.1002/iid3.1156.
Immune abnormalities in IgA nephropathy.
Gentile M, Sanchez-Russo L, Riella L, Verlato A, Manrique J, Granata S
Clin Kidney J. 2023; 16(7):1059-1070.
PMID: 37398689
PMC: 10310525.
DOI: 10.1093/ckj/sfad025.
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy.
Nihei Y, Suzuki H, Suzuki Y
Front Immunol. 2023; 14:1165394.
PMID: 37114051
PMC: 10126238.
DOI: 10.3389/fimmu.2023.1165394.
Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy.
Nihei Y, Haniuda K, Higashiyama M, Asami S, Iwasaki H, Fukao Y
Sci Adv. 2023; 9(12):eadd6734.
PMID: 36947618
PMC: 10032602.
DOI: 10.1126/sciadv.add6734.
Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation.
Luvizotto M, Menezes-Silva L, Woronik V, Monteiro R, Camara N
Front Cell Dev Biol. 2022; 10:993716.
PMID: 36467425
PMC: 9715425.
DOI: 10.3389/fcell.2022.993716.
IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment.
Lai L, Liu S, Azrad M, Hall S, Hao C, Novak J
J Clin Med. 2021; 10(21).
PMID: 34768371
PMC: 8584405.
DOI: 10.3390/jcm10214851.
Immunoglobulin A, an Active Liaison for Host-Microbiota Homeostasis.
Abokor A, McDaniel G, Golonka R, Campbell C, Brahmandam S, Yeoh B
Microorganisms. 2021; 9(10).
PMID: 34683438
PMC: 8539215.
DOI: 10.3390/microorganisms9102117.
The mucosal immune system and IgA nephropathy.
Gesualdo L, Di Leo V, Coppo R
Semin Immunopathol. 2021; 43(5):657-668.
PMID: 34642783
PMC: 8551125.
DOI: 10.1007/s00281-021-00871-y.
Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in Clinic.
Kim J, Lee J, Kim H, Kwak M, Kang T
Int J Mol Sci. 2021; 22(17).
PMID: 34502398
PMC: 8431278.
DOI: 10.3390/ijms22179489.
Indian scenario of IgA nephropathy: a systematic review and meta-analysis.
Khairwa A
Afr Health Sci. 2021; 21(1):159-165.
PMID: 34394293
PMC: 8356571.
DOI: 10.4314/ahs.v21i1.21.
Complement activation in IgA nephropathy.
Medjeral-Thomas N, Cook H, Pickering M
Semin Immunopathol. 2021; 43(5):679-690.
PMID: 34379175
PMC: 8551128.
DOI: 10.1007/s00281-021-00882-9.
Multimodal imaging of bilateral ischemic retinal vasculopathy associated with Berger's IgA nephropathy: case report.
El Matri K, Amoroso F, Zambrowski O, Miere A, Souied E
BMC Ophthalmol. 2021; 21(1):204.
PMID: 33964916
PMC: 8106839.
DOI: 10.1186/s12886-021-01935-1.
IgA vasculitis with nephritis: update of pathogenesis with clinical implications.
Hastings M, Rizk D, Kiryluk K, Nelson R, Zahr R, Novak J
Pediatr Nephrol. 2021; 37(4):719-733.
PMID: 33818625
PMC: 8490493.
DOI: 10.1007/s00467-021-04950-y.
